Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income including noncontrolling interests	$ 255,810	$ 158,756
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	71,261	80,182
Impairment and other charges	16,055	130,411
Share-based compensation expense related to equity classified awards	39,163	43,141
Non-cash restructuring and other related charges	4,329	6,126
Amortization and write-off of program rights	601,640	622,204
Amortization of deferred carriage fees	16,138	21,088
Unrealized foreign currency transaction (gain) loss	(10,025)	9,242
Amortization of deferred financing costs and discounts on indebtedness	5,820	6,039
Loss on extinguishment of debt	22,074	2,908
Bad debt expense	4,900	340
Deferred income taxes	31,765	12,403
Gain on investments	(4,554)	0
Write-down of non-marketable equity securities and note receivable	0	5,103
Other, net	(3,429)	(10,696)
Changes in assets and liabilities:
Accounts receivable, trade (including amounts due from related parties, net)	38,514	92,328
Prepaid expenses and other assets	(62,799)	79,098
Program rights and obligations, net	(967,172)	(565,267)
Income taxes payable	(5,235)	17,265
Deferred revenue	6,837	(2,234)
Deferred carriage fees, net	(29,207)	(15,057)
Accounts payable, accrued liabilities and other liabilities	12,099	(49,293)
Net cash provided by operating activities	43,984	644,087
Cash flows from investing activities:
Capital expenditures	(29,969)	(34,990)
Return of capital from investees	0	924
Payments for acquisition of a business, net of cash acquired	(19,072)	0
Acquisition of investment securities	(28,397)	(4,111)
Cash paid on distribution of business	(7,052)	0
Principal payment received on loan to investee	20,000	3,750
Proceeds from sale of investments	95,370	10,000
Net cash provided by (used in) investing activities	30,880	(24,427)
Cash flows from financing activities:
Proceeds from the issuance of long-term debt	986,000	6,000
Principal payments on long-term debt	(1,015,000)	(242,500)
Deemed repurchases of restricted stock units	(34,648)	(8,947)
Purchase of treasury stock	0	(102,938)
Proceeds from stock option exercises	12,100	0
Principal payments on finance lease obligations	(2,866)	(2,404)
Contributions from noncontrolling interests	2,701	0
Distributions to noncontrolling interests	(14,906)	(13,955)
Net cash used in financing activities	(66,619)	(364,744)
Net increase in cash and cash equivalents	8,245	254,916
Effect of exchange rate changes on cash and cash equivalents	(25,804)	774
Cash and cash equivalents at beginning of period	888,526	816,170
Cash and cash equivalents at end of period	$ 870,967	$ 1,071,860